Fulcrum Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases, will be participating in the RBC Capital Markets Global Healthcare Conference on May 21, 2025. The company will conduct a fireside chat at 3:35 pm ET, which will be webcast and accessible through their website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.